Evidence map›Paper›PMID 38165384›Full record

ArticleNeurology2024

Assignment Completed: The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis

Steven Galetta, Wallace Brownlee

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Steven GalettaFrom the NYU Grossman School of Medicine (S.G.), New York; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation (W.J.B.), UCL Institute of Neurology, London; and National Institute for Health and Care Research (NIHR), University College London Hospitals Biomedic, United Kingdom.ORCID 0000-0003-3781-7324
Wallace BrownleeFrom the NYU Grossman School of Medicine (S.G.), New York; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation (W.J.B.), UCL Institute of Neurology, London; and National Institute for Health and Care Research (NIHR), University College London Hospitals Biomedic, United Kingdom.ORCID 0000-0003-0481-8902

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optic neuritis has long been considered a characteristic finding of multiple sclerosis and the initial manifestation of the disorder in about 25% of patients. Approximately 70% of patients will experience optic nerve dysfunction during their disease course.

Indexed as

Multiple SclerosisOptic NeuritisDisease ProgressionHumansOptic Nerve

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.